Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland
· Delayed Price · Currency is CHF
14.80
-0.28 (-1.86%)
Apr 29, 2026, 5:30 PM CET
Newron Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -13.24 | 15.84 | -16.22 | -17.49 | -14.9 | |
| Depreciation & Amortization | 0.17 | 0.19 | 0.2 | 0.2 | 0.21 | |
| Stock-Based Compensation | 0.21 | 0.26 | 0.2 | 0.48 | 0.76 | |
| Other Operating Activities | 5.58 | 3.85 | 4.17 | 3.83 | 2.75 | |
| Change in Accounts Receivable | 43.34 | -44.22 | -1.31 | -0.88 | 1.75 | |
| Change in Accounts Payable | -4.42 | 2.63 | 0.58 | 0.58 | -3.95 | |
| Change in Other Net Operating Assets | 0.7 | 3.84 | 2.24 | 2.19 | 1.93 | |
| Operating Cash Flow | 32.35 | -17.61 | -10.14 | -11.09 | -11.45 | |
| Capital Expenditures | -0.05 | -0.01 | -0.01 | -0.02 | -0.02 | |
| Sale (Purchase) of Intangibles | -0 | - | - | - | - | |
| Investment in Securities | -13.62 | 3.17 | 3.26 | -0.3 | 8.44 | |
| Investing Cash Flow | -13.66 | 3.16 | 3.25 | -0.32 | 8.42 | |
| Long-Term Debt Issued | - | - | - | - | 15 | |
| Long-Term Debt Repaid | -13.78 | -0.19 | -0.19 | -0.19 | -0.17 | |
| Net Debt Issued (Repaid) | -13.78 | -0.19 | -0.19 | -0.19 | 14.83 | |
| Issuance of Common Stock | 0.35 | 15.41 | - | - | - | |
| Other Financing Activities | - | -0.17 | - | - | - | |
| Financing Cash Flow | -13.43 | 15.05 | -0.19 | -0.19 | 14.83 | |
| Net Cash Flow | 5.25 | 0.6 | -7.09 | -11.6 | 11.81 | |
| Free Cash Flow | 32.3 | -17.63 | -10.15 | -11.11 | -11.47 | |
| Free Cash Flow Margin | 168.89% | -34.30% | -112.08% | -182.31% | -198.98% | |
| Free Cash Flow Per Share | 1.62 | -0.86 | -0.57 | -0.62 | -0.64 | |
| Cash Interest Paid | 3.29 | 1.9 | 1.2 | 1.23 | 0.87 | |
| Levered Free Cash Flow | 39.32 | -26.67 | -9.22 | -9.64 | -10.04 | |
| Unlevered Free Cash Flow | 42.07 | -23.95 | -6.61 | -7.17 | -8.22 | |
| Change in Working Capital | 39.62 | -37.75 | 1.51 | 1.89 | -0.26 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.